Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
327.79
-0.07 (-0.02%)
At close: Jun 26, 2026, 4:00 PM EDT
333.58
+5.79 (1.77%)
After-hours: Jun 26, 2026, 7:39 PM EDT
PRAX Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for PRAX stock have an average target of 614.94, with a low estimate of 162 and a high estimate of 1,201. The average target predicts an increase of 87.60% from the current stock price of 327.79.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PRAX stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 13 | 12 | 13 | 13 | 13 |
| Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 15 | 17 | 16 | 17 | 17 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains $525 → $550 | Buy | Maintains | $525 → $550 | +67.79% | Jun 23, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $731 | Buy | Reiterates | $731 | +123.01% | Jun 23, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $1,200 | Buy | Maintains | $1,200 | +266.09% | Jun 18, 2026 |
| RBC Capital | RBC Capital | Buy Initiates $449 | Buy | Initiates | $449 | +36.98% | Jun 17, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $1,245 → $1,201 | Buy | Maintains | $1,245 → $1,201 | +266.39% | Jun 8, 2026 |
Financial Forecast
Revenue This Year
4.34M
Revenue Next Year
328.47M
from 4.34M
Increased by 7,470.73%
EPS This Year
-15.20
from -13.48
EPS Next Year
-9.81
from -15.20
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 12.1M | 655.0M | |
| Avg | 4.3M | 328.5M | |
| Low | n/a | 140.2M |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 14,995.9% | 552.5% |
| Avg | 7,470.7% | 234.8% |
| Low | 3,132.0% | 57.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -13.25 | 3.38 | |
| Avg | -15.20 | -9.81 | |
| Low | -22.94 | -22.60 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.